Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Goetz

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
Oncology (Williston Park, N.Y.)|February 4, 2010
Tamoxifen, endoxifen, and CYP2D6: the rules for evaluating a predictive factorMatthew P Goetz
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
The development of endoxifen for breast cancerMatthew P Goetz
Clinical Advances in Hematology & Oncology : H&O|October 23, 2010
Update on CYP2D6 and its impact on tamoxifen therapyMatthew P Goetz
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
Update on CYP2D6 and TamoxifenMatthew P Goetz
Expert Review of Anticancer Therapy|July 24, 2004
Developments in combination chemotherapy for colorectal cancerMatthew P Goetz, Axel Grothey
Clinical Colorectal Cancer|June 24, 2004
Oxaliplatin plus oral fluoropyrimidines in colorectal cancerAxel Grothey, Matthew P Goetz
Cancer|September 28, 2007
Early discontinuation of tamoxifen: a lesson for oncologistsMatthew P Goetz, James Ingle
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Window-of-Opportunity Trials in the Preoperative Setting: Insights Into Drug Development for Estrogen Receptor-Positive Breast CancerMatthew P Goetz, Vera J Suman
Nature Clinical Practice. Oncology|September 13, 2007
Aromatase inhibitors and tamoxifen: where do we go from here?Matthew P Goetz, Charles L Loprinzi
Annals of Surgical Oncology|March 3, 2015
Landscape of neoadjuvant therapy for breast cancerTufia C Haddad, Matthew P Goetz
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Oncology (Williston Park, N.Y.)|February 4, 2010
Tamoxifen, endoxifen, and CYP2D6: the rules for evaluating a predictive factorMatthew P Goetz
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
The development of endoxifen for breast cancerMatthew P Goetz
Clinical Advances in Hematology & Oncology : H&O|October 23, 2010
Update on CYP2D6 and its impact on tamoxifen therapyMatthew P Goetz
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
Update on CYP2D6 and TamoxifenMatthew P Goetz
Expert Review of Anticancer Therapy|July 24, 2004
Developments in combination chemotherapy for colorectal cancerMatthew P Goetz, Axel Grothey
Clinical Colorectal Cancer|June 24, 2004
Oxaliplatin plus oral fluoropyrimidines in colorectal cancerAxel Grothey, Matthew P Goetz
Cancer|September 28, 2007
Early discontinuation of tamoxifen: a lesson for oncologistsMatthew P Goetz, James Ingle
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Window-of-Opportunity Trials in the Preoperative Setting: Insights Into Drug Development for Estrogen Receptor-Positive Breast CancerMatthew P Goetz, Vera J Suman
Nature Clinical Practice. Oncology|September 13, 2007
Aromatase inhibitors and tamoxifen: where do we go from here?Matthew P Goetz, Charles L Loprinzi
Annals of Surgical Oncology|March 3, 2015
Landscape of neoadjuvant therapy for breast cancerTufia C Haddad, Matthew P Goetz
Pageof 27